Big Picture Bio is a London-based biotech that uses a generative world model to design combination therapies for cancer and immune-mediated diseases, simulating how tumours, immune cells and surrounding tissue interact across disease sites and patient subgroups. The platform pairs AI-driven modelling with targeted wet-lab validation, and its predictions have been benchmarked against real-world clinical outcomes, including data presented at ASCO. The company was founded in 2026 by Deep Science Ventures veterans Kerstin Papenfuss and Mark Hammond.
1
Round
1
Industry
4
Tags
Sep 17, 2026
Latest raise
Funding activity · 1 round
Sep 17, 2026
GBP 1.5M
Pre-Seed
Led by Exceptional Ventures
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
